Tumor Only Sequencing Could Be Misleading
Many hospitals sequence patients’ tumor genomes to personalize their treatment – but without sequencing normal tissue, this can harm rather than heal.
Michael Schubert |
Sequencing the tumors of cancer patients is an increasingly common practice among healthcare providers. The testing is done in an attempt to personalize each patient’s therapy as much as possible – but it may actually be negatively impacting treatment.
Read the full article now
Log in or register to read this article in full and gain access to The Pathologist’s entire content archive. It’s FREE and always will be!
Or register now - it’s free and always will be!
You will benefit from:
- Unlimited access to ALL articles
- News, interviews & opinions from leading industry experts
- Receive print (and PDF) copies of The Pathologist magazine
Or Login via Social Media
By clicking on any of the above social media links, you are agreeing to our Privacy Notice.